Case Report
Accepted on 14 Aug 2025
The efficacy of low-dose Anlotinib as a first-line treatment for frail patients with lung adenocarcinoma and its bridging significance for subsequent treatment: case report
in Pulmonary Medicine
Case Report
Accepted on 14 Aug 2025
in Pulmonary Medicine
Original Research
Accepted on 14 Aug 2025
in Cardiovascular Surgery
Correction
Accepted on 14 Aug 2025
in Vaccines and Molecular Therapeutics
Original Research
Accepted on 14 Aug 2025
in Decision Neuroscience
Review
Accepted on 14 Aug 2025
in General Cardiovascular Medicine
Case Report
Accepted on 14 Aug 2025
in Cancer Molecular Targets and Therapeutics
Original Research
Accepted on 14 Aug 2025
in Cancer Molecular Targets and Therapeutics
Original Research
Accepted on 14 Aug 2025
in Occupational Health and Safety
Systematic Review
Accepted on 14 Aug 2025
in Gender, Sex and Sexualities
Original Research
Accepted on 14 Aug 2025
in Geoscience and Society
Clinical Trial
Accepted on 14 Aug 2025
in Vaccines and Molecular Therapeutics
Mini Review
Accepted on 14 Aug 2025
in Politics of Technology
Original Research
Accepted on 14 Aug 2025
in Analytical Chemistry
Case Report
Accepted on 14 Aug 2025
in Brain Health and Clinical Neuroscience
Case Report
Accepted on 14 Aug 2025
in Clinical Diabetes
Systematic Review
Accepted on 14 Aug 2025
in Sleep Disorders